Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Payables (2020 - 2026)

IceCure Medical has reported Payables over the past 7 years, most recently at $988000.0 for Q1 2026.

  • For Q1 2026, Payables changed N/A year-over-year to $988000.0; the TTM value through Mar 2026 reached $988000.0, changed N/A, while the annual FY2025 figure was $863000.0, 29.95% down from the prior year.
  • Payables was $988000.0 for Q1 2026 at IceCure Medical, up from $863000.0 in the prior quarter.
  • Across five years, Payables topped out at $1.2 million in Q4 2024 and bottomed at $502000.0 in Q4 2023.
  • The 5-year median for Payables is $863000.0 (2025), against an average of $859800.0.
  • Year-over-year, Payables surged 145.42% in 2024 and then fell 29.95% in 2025.
  • Over 5 years, Payables stood at $714000.0 in 2022, then dropped by 29.69% to $502000.0 in 2023, then surged by 145.42% to $1.2 million in 2024, then fell by 29.95% to $863000.0 in 2025, then rose by 14.48% to $988000.0 in 2026.
  • The last three reported values for Payables were $988000.0 (Q1 2026), $863000.0 (Q4 2025), and $1.2 million (Q4 2024) per Business Quant data.